|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.09.26 - 12:54
|
Australia launches investigation after OpenAI agent hacked healthcare database (The Guardian)
|
|
|
Prime minister says he told Sam Altman he was disappointed it had taken OpenAI 'way too long' to disclose breachAnthony Albanese says an artificial intelligence agent developed by OpenAI hacked Medicare in June and the tech giant notified the government earlier this month using an email sent to a “public mailbox”.Australia's prime minister made the comments at the UN summit in New York, saying it appeared no personal information had been accessed in the AI breach. Continue reading......
|
|
|
|
|
|
|
|
|
23.09.26 - 16:51
|
Linnemann konkretisiert Kanzler-Aussagen zu Krankenkassen (DPA-AFX)
|
|
|
BERLIN (dpa-AFX) - Nach den Äußerungen von Kanzler Friedrich Merz (CDU) zu einem Gerechtigkeitsproblem zwischen gesetzlich und privat Krankenversicherten hat Gesundheitsminister Carsten Linnemann konkrete Ansatzpunkte genannt. Der CDU-Politiker wies in ......
|
|
|
|
|
|
|
23.09.26 - 06:01
|
Heidi CEO on AI in Healthcare, $900M valuation (Bloomberg)
|
|
|
Thomas Kelly, CEO and Co-founder of Melbourne-based AI Healthcare startup firm Heidi, discusses its latest $100M fundraising around that took the company to a $900M valuation.
He also talks about the company's business strategies and plans to expand to more markets, using AI to help doctors streamline research, clinical workflows, and provide efficient consultations for patients.
He speaks exclusively with Shery Ahn on "Bloomberg: The Asia Trade". (Source: Bloomberg)...
|
|
|
23.09.26 - 04:00
|
Rising US scrutiny on clinical trials could threaten China′s biotech advantage: analysts (SCMP)
|
|
|
China's edge in fast, cost-effective early clinical trials has propelled its emergence as a global biopharmaceutical powerhouse, but there is a risk that the United States could take steps to curb that advantage, according to analysts.
US lawmakers and officials at the Food and Drug Administration (FDA) have raised the alarm about American pharmaceutical companies' growing reliance on conducting early clinical trials in China, flagging the opaqueness of the process and the need to keep medical......
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
